D81.32 Adenosine deaminase 2 deficiency

Name of the Condition

• Adenosine deaminase 2 deficiency

Summary

Adenosine deaminase 2 (ADA2) deficiency is a rare inherited disorder that disrupts immune system function and blood vessel development. This condition results from genetic mutations affecting the ADA2 enzyme, leading to inflammation, vasculitis, and immunodeficiency. The deficiency causes abnormal immune responses and vascular damage, resulting in recurrent infections, fevers, and skin or organ inflammation. Without treatment, the disorder can progress to severe complications, including organ damage or failure.

Causes

ADA2 deficiency is caused by genetic mutations in the ADA2 gene, which provides instructions for producing the adenosine deaminase 2 enzyme. These mutations reduce or eliminate enzyme activity, disrupting normal immune regulation and vascular health. The condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two mutated copies of the gene (one from each parent) to develop the disorder. Carriers (those with one mutated copy) typically do not show symptoms.

Risk Factors

• Genetic predisposition, often with a family history of immunodeficiency or vasculitis.
• Consanguinity (parents who are closely related) increasing the risk of autosomal recessive inheritance.
• Ethnic or familial clustering in some populations.

Symptoms

• Recurrent fevers and infections (e.g., skin, respiratory, or gastrointestinal).
• Skin manifestations, such as rashes, nodules, or ulcers.
• Vasculitis affecting small to medium blood vessels, leading to organ inflammation (e.g., liver, gastrointestinal tract, or nervous system).
• Neurological symptoms, including stroke or peripheral neuropathy.
• Hematologic abnormalities, such as anemia or thrombocytopenia.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory testing, and genetic analysis. Blood tests may show elevated inflammatory markers, abnormal immune cell counts, or reduced ADA2 enzyme activity. Imaging studies (e.g., MRI or angiography) can detect vascular abnormalities. Genetic testing confirms the presence of ADA2 gene mutations. Biopsies of affected tissues (e.g., skin or blood vessels) may reveal inflammatory changes consistent with vasculitis.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. Immunosuppressive therapies (e.g., corticosteroids or biologics) reduce inflammation and vasculitis. Antibiotics or antiviral medications treat infections. Hematopoietic stem cell transplantation (HSCT) may be considered for severe cases to restore immune function. Regular monitoring of organ health and immune status is essential.

Prognosis and Follow-Up

Prognosis varies depending on the severity of symptoms and response to treatment. Early diagnosis and intervention improve outcomes, but some individuals may experience progressive organ damage or recurrent infections. Long-term follow-up includes regular assessments of immune function, vascular health, and organ function. Adjustments to treatment plans may be necessary based on disease activity.

Complications

• Severe infections due to immunodeficiency.
• Organ damage from vasculitis (e.g., liver, kidney, or neurological impairment).
• Chronic inflammation leading to tissue scarring or functional loss.
• Increased risk of malignancy in rare cases.

Lifestyle & Prevention

• Prompt treatment of infections to prevent complications.
• Avoiding triggers that may exacerbate inflammation (e.g., infections or stress).
• Regular medical monitoring to detect early signs of organ involvement.
• Genetic counseling for families with a history of the disorder.

When to Seek Professional Help

Seek immediate medical attention for:

• High, persistent fevers or unexplained rashes.
• Signs of infection (e.g., cough, diarrhea, or wound drainage).
• Neurological symptoms (e.g., weakness, numbness, or confusion).
• Unexplained organ pain or swelling.

Tips for Medical Coders

Document the presence of ADA2 deficiency using ICD-10-CM code D81.32. Ensure clinical documentation supports the diagnosis, including genetic confirmation or characteristic symptoms (e.g., vasculitis, recurrent infections). Code assignment should reflect the specific subtype of ADA2 deficiency, as it differs from other ADA-related disorders. Verify that the code aligns with the patient's clinical presentation and diagnostic findings.